Hunting for better biomarkers of response

IMMUNO-ONCOLOGY INSIGHTS

June 2021

Hunting for better biomarkers of response

Download PDF

Expert Insight

Digital pathology for the identification of prognostic biomarkers in head and neck cancer

Digital pathology for the identification of prognostic biomarkers in head and neck cancer

Rasha Abu-Eid, Frank James Ward

Interview

Driving the development of microbiome-based biomarkers of patient response to immunotherapy

Driving the development of microbiome-based biomarkers of patient response to immunotherapy

Ricardo Fernandes, John Lenehan, Saman Maleki

Reflecting on Merck’s I-O biomarker development journey

Reflecting on Merck’s I-O biomarker development journey

Eric H Rubin, MD

Expert Roundtable Video

Hunting for better biomarkers of response: where is real progress being made in understanding why patients do and don’t respond to I-O therapeutics?

Hunting for better biomarkers of response: where is real progress being made in understanding why patients do and don’t respond to I-O therapeutics?

D Adil Daud, S Fling, PhD, J Rossi et al.

Expert Roundtable

Hunting for better biomarkers of response: where is real progress being made in understanding why patients do and don’t respond to I-O therapeutics?

Hunting for better biomarkers of response: where is real progress being made in understanding why patients do and don’t respond to I-O therapeutics?

Review

CTLA-4 expression by human tumor cells and its impact on immunotherapeutic strategies: a systematic review

CTLA-4 expression by human tumor cells and its impact on immunotherapeutic strategies: a systematic review

F Abdulkhaleq, N Larossi, O Ogbonda et al.

Viewpoint

Leveraging the advantages of liquid biopsy for predictive and prognostic biomarkers in R&D

Leveraging the advantages of liquid biopsy for predictive and prognostic biomarkers in R&D

Chamindie Punyadeera